Additional file 4 of Capmatinib is an effective treatment for MET-fusion driven pediatric high-grade glioma and synergizes with radiotherapy

Additional file 4: Supplementary Table 2. EC50 and EC90 values of capmatinib (cap) and crizotinib (cri) following 3-day dose response assays. To calculate unbound EC50 and EC90 values, total values were multiplied with unbound drug fractions in culture media (Table 1).补充材料4：补充表2。卡马替尼（capmatinib，CAP）与克唑替尼（crizotinib，CRI）经3天剂量反应试验测得的半数有效浓度（EC50）与90%有效浓度（EC90）数值。为计算游离态EC50与EC90数值，需将总浓度值乘以细胞培养基中的游离药物分数（见表1）。